Effect of angiotensin II receptor antagonist on the plasma levels of calcitonin gene-related peptide and endothelin in the patients with diabetic nephrophy
Cui-ping Cao, Guoliang Liu, Binhong Wen
Abstract
Cui-ping Cao, Guoliang Liu, Binhong Wen
Abstract
The plasma levels of calcitonin gene-related peptide (CGRP) and endothelin (ET) were assayed in 76 patients with diabetic nephropathy (DN) and 23 healthy subjects, and the changes of CGRP and ET levels after treatment with angiotensin Ⅱ receptor antagonist (ARBS) were observed. The results showed that CGRP level was increased and ET level decreased after treatment with ARBS, which seemed to delay the onset and development of DN.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The plasma levels of calcitonin gene-related peptide (CGRP) and endothelin (ET) were assayed in 76 patients with diabetic nephropathy (DN) and 23 healthy subjects, and the changes of CGRP and ET levels after treatment with angiotensin Ⅱ receptor antagonist (ARBS) were observed. The results showed that CGRP level was increased and ET level decreased after treatment with ARBS, which seemed to delay the onset and development of DN.
Key concepts: Calcitonin gene-related peptide, Endocrinology, Internal medicine, Endothelin receptor, Calcitonin, Antagonist, Diabetic nephropathy, Medicine